nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethynodiol—PGR—Betamethasone—psoriasis	0.272	0.632	CbGbCtD
Ethynodiol—PGR—Dexamethasone—psoriasis	0.158	0.368	CbGbCtD
Ethynodiol—Levonorgestrel—Hydrocortisone—psoriasis	0.1	0.178	CrCrCtD
Ethynodiol—Megestrol acetate—Hydrocortisone—psoriasis	0.1	0.178	CrCrCtD
Ethynodiol—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.0892	0.158	CrCrCtD
Ethynodiol—Norethindrone—Hydrocortisone—psoriasis	0.0806	0.143	CrCrCtD
Ethynodiol—Progesterone—Hydrocortisone—psoriasis	0.0678	0.12	CrCrCtD
Ethynodiol—Testosterone Propionate—Hydrocortisone—psoriasis	0.0678	0.12	CrCrCtD
Ethynodiol—Progesterone—Prednisolone—psoriasis	0.057	0.101	CrCrCtD
Ethynodiol—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.00033	0.0497	CbGpPWpGaD
Ethynodiol—PGR—Ovarian Infertility Genes—VDR—psoriasis	0.000301	0.0452	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptors—VDR—psoriasis	0.000262	0.0394	CbGpPWpGaD
Ethynodiol—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000238	0.0357	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000207	0.0311	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptors—PPARG—psoriasis	0.000183	0.0275	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000179	0.027	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000165	0.0249	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000155	0.0233	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—VDR—psoriasis	0.000154	0.0231	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000153	0.023	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—REL—psoriasis	0.000152	0.0228	CbGpPWpGaD
Ethynodiol—PGR—Cellular roles of Anthrax toxin—TNF—psoriasis	0.00015	0.0226	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000144	0.0217	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000132	0.0199	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000122	0.0184	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000121	0.0183	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen signaling pathway—JUN—psoriasis	0.000114	0.0171	CbGpPWpGaD
Ethynodiol—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	0.000109	0.0164	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—PPARG—psoriasis	0.000107	0.0161	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	9.2e-05	0.0138	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—IL10—psoriasis	9.17e-05	0.0138	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—TARS—psoriasis	9.16e-05	0.0138	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	8.99e-05	0.0135	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—IL4—psoriasis	8.92e-05	0.0134	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	8.53e-05	0.0128	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	8.47e-05	0.0127	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	8.39e-05	0.0126	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	8.16e-05	0.0123	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	8.12e-05	0.0122	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	8.08e-05	0.0122	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	8.06e-05	0.0121	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—LEP—psoriasis	7.14e-05	0.0107	CbGpPWpGaD
Ethynodiol—ESR1—FOXA1 transcription factor network—JUN—psoriasis	6.76e-05	0.0102	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.28e-05	0.00945	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	6.18e-05	0.0093	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—CARM1—psoriasis	5.99e-05	0.00901	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	5.75e-05	0.00865	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.7e-05	0.00857	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of Telomerase—IFNG—psoriasis	5.52e-05	0.0083	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—IFNG—psoriasis	5.39e-05	0.00811	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—TARS—psoriasis	5.38e-05	0.00809	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	5.36e-05	0.00806	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—JUN—psoriasis	5.35e-05	0.00804	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—TYK2—psoriasis	5.28e-05	0.00794	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	5.02e-05	0.00754	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	5.01e-05	0.00753	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.88e-05	0.00735	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of Telomerase—JUN—psoriasis	4.77e-05	0.00718	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—JUN—psoriasis	4.66e-05	0.00701	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of Telomerase—NFKB1—psoriasis	4.59e-05	0.00691	CbGpPWpGaD
Ethynodiol—ESR1—LKB1 signaling events—TP53—psoriasis	4.54e-05	0.00684	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—NFKB1—psoriasis	4.25e-05	0.00639	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—HCAR2—psoriasis	4.24e-05	0.00638	CbGpPWpGaD
Ethynodiol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.15e-05	0.00624	CbGpPWpGaD
Ethynodiol—ESR1—Leptin signaling pathway—STAT3—psoriasis	3.82e-05	0.00574	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.75e-05	0.00564	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TAGAP—psoriasis	3.68e-05	0.00553	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—VDR—psoriasis	3.58e-05	0.00538	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—CARM1—psoriasis	3.51e-05	0.00529	CbGpPWpGaD
Ethynodiol—ESR1—ATF-2 transcription factor network—IL6—psoriasis	3.23e-05	0.00486	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.15e-05	0.00474	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—TYK2—psoriasis	3.1e-05	0.00466	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—TP53—psoriasis	3.08e-05	0.00463	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—CARM1—psoriasis	2.88e-05	0.00434	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—IL6—psoriasis	2.82e-05	0.00424	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—IL6—psoriasis	2.58e-05	0.00388	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.52e-05	0.00379	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—PPARG—psoriasis	2.49e-05	0.00375	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—HCAR2—psoriasis	2.49e-05	0.00375	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.43e-05	0.00365	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—CCL20—psoriasis	2.2e-05	0.00332	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.2e-05	0.00331	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TAGAP—psoriasis	2.16e-05	0.00325	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—VDR—psoriasis	2.1e-05	0.00316	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.09e-05	0.00314	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.01e-05	0.00302	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.82e-05	0.00274	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—VDR—psoriasis	1.72e-05	0.00259	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—CARM1—psoriasis	1.69e-05	0.00254	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.66e-05	0.0025	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.56e-05	0.00235	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—IL6—psoriasis	1.51e-05	0.00228	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—PPARG—psoriasis	1.46e-05	0.0022	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.38e-05	0.00207	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—CCL20—psoriasis	1.29e-05	0.00195	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—SOCS1—psoriasis	1.21e-05	0.00183	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—PPARG—psoriasis	1.2e-05	0.00181	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—VDR—psoriasis	1.01e-05	0.00152	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—LEP—psoriasis	8.96e-06	0.00135	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—APOE—psoriasis	8.96e-06	0.00135	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NFKBIA—psoriasis	8.35e-06	0.00126	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—SOCS1—psoriasis	7.12e-06	0.00107	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—PPARG—psoriasis	7.04e-06	0.00106	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TYK2—psoriasis	6.84e-06	0.00103	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—CXCL8—psoriasis	5.95e-06	0.000895	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—JUN—psoriasis	5.53e-06	0.000832	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—NFKB1—psoriasis	5.33e-06	0.000801	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—APOE—psoriasis	5.26e-06	0.000791	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—LEP—psoriasis	5.26e-06	0.000791	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NFKBIA—psoriasis	4.9e-06	0.000737	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—VEGFA—psoriasis	4.83e-06	0.000727	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—STAT3—psoriasis	4.79e-06	0.00072	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TYK2—psoriasis	4.01e-06	0.000604	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TP53—psoriasis	3.65e-06	0.000549	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—CXCL8—psoriasis	3.49e-06	0.000526	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IL6—psoriasis	3.34e-06	0.000503	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—JUN—psoriasis	3.25e-06	0.000489	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—NFKB1—psoriasis	3.13e-06	0.00047	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—VEGFA—psoriasis	2.84e-06	0.000427	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—STAT3—psoriasis	2.81e-06	0.000423	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TP53—psoriasis	2.14e-06	0.000323	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IL6—psoriasis	1.96e-06	0.000295	CbGpPWpGaD
